Re: | AntriaBio, Inc. – Request for Acceleration | |
Registration Statement on Form S-1 (SEC File No. 333-204434) filed with the United States Securities and Exchange Commission on May 22, 2015,
as amended on July 7, 2015 and July 22, 2015
|
● |
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
|
|
● |
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
|
|
● |
the company may not assert the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
|
Very truly yours, | ||
ANTRIABIO, INC. | ||
By: | /s/ Nevan Elam | |
Name: | Nevan Elam | |
Title: | Chief Executive Officer |